JonesResearch lowered the firm’s price target on Lantheus (LNTH) to $120 from $134 and keeps a Buy rating on the shares following the Q1 report. With Pylarify facing competitive pressure and its net sales down 0.5% year-over- year, an ongoing business reorganization and reduced …
Roth Capital analyst Leo Mariani lowered the firm’s price target on Murphy Oil (MUR) to $27 from $28 and keeps a Buy rating on the shares. Murphy Oil’s Q1 cash flow per share was 1% above consensus and 2025 guidance for capital expenditures and …
Scotiabank raised the firm’s price target on Fiverr (FVRR) to $34 from $31 and keeps an Outperform rating on the shares. Thie quarter was “solid” and went as-expected, giving the firm more confidence in the company’s shift toward a higher-quality, more monetizable demand base, …
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), …
We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where MannKind Corporation (NASDAQ:MNKD) stands against other best cancer stocks to invest in for long-term gain. Surging …
We recently compiled a list of the 10 Jim Cramer Stocks with Huge Upside Potential. In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against the other Jim Cramer stocks with huge upside potential. During the …
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: Protect Your Portfolio Against Market Uncertainty Discover companies with …
We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at where Krystal Biotech, Inc. (NASDAQ:KRYS) stands against other best cancer stocks to invest in for long-term gain. …
Ingevity Corporation NGVT recorded a first-quarter 2025 profit of $20.5 million or 56 cents per share. This compared favorably with a loss of $56 million or a loss of $1.54 per share in the year-ago quarter. Excluding one-time items, adjusted earnings in the quarter …
CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford …